Identification and assessment of the 1,6-dihydroxy-pyridin-2-one moiety as privileged scaffold for HBV ribonuclease H inhibition

Authors:

Abstract
No abstract available
Funding Information
  • National Institutes of Health (R01 AI150610, R21 AI124672)
  • Gilead Sciences

This publication has 27 references indexed in Scilit: